Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

• मुख्य लेखकों: Hejing Bao (लेखक), Jiani Zhang (लेखक), Yuhuan Wang (लेखक), Zhiting Chen (लेखक), Xi Luo (लेखक), Ting Li (लेखक), Haoran Su (लेखक), Hehong Bao (लेखक), Xiaolong Cao (लेखक), Liping Lin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

We report a case of an advanced non-small cell lung cancer (NSCLC) patient with brain metastasis, RET fusion, and high expression of programmed death ligand 1 (PD-L1) at initial treatment. After receiving radiotherapy for the brain metastasis, the patient started with anlotinib and added immunothera...